Streetbeat News

Price Targets

TWOU

Morgan Stanley analyst Josh Baer has maintained an Equal-Weight rating on 2U (NASDAQ:TWOU) but lowered the price target from $4.5 to $3.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:21 pm

SPOT

Benchmark analyst Mark Zgutowicz maintains a Buy rating on Spotify Technology (NYSE:SPOT) but lowers the price target from $205 to $195.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:18 pm

ETSY

Wedbush analyst Seth Basham has reiterated a Neutral rating on Etsy (NASDAQ:ETSY) and maintained a $70 price target.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:14 pm

STRO

Wedbush analyst David Nierengarten has reiterated an Outperform rating on Sutro Biopharma (NASDAQ:STRO) and maintained a $12 price target.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:11 pm

WOLF

Goldman Sachs analyst Brian Lee has maintained a 'Buy' rating on Wolfspeed (NYSE:WOLF) but lowered the price target from $66 to $57.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:10 pm

ORIC

Wedbush analyst David Nierengarten has reiterated his 'Outperform' rating on ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining a price target of $14.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:09 pm

VCYT

Goldman Sachs analyst Matthew Sykes has maintained a 'Buy' rating on Veracyte (NASDAQ:VCYT) but lowered the price target from $37 to $32.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:07 pm

SEDG

Goldman Sachs analyst Brian Lee has maintained a Neutral rating on SolarEdge Technologies (NASDAQ:SEDG) and lowered the price target from $254 to $131.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:05 pm

RF

Goldman Sachs analyst Ryan Nash maintains a Buy rating on Regions Financial (NYSE:RF) but lowers the price target from $22.5 to $19.5.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:02 pm

NEO

Goldman Sachs analyst Matthew Sykes has maintained a 'Buy' rating on NeoGenomics (NASDAQ:NEO) but lowered the price target from $19 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2023 | 1:00 pm